Compare ALDX & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALDX | CCLD |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.1M | 98.6M |
| IPO Year | 2014 | 2013 |
| Metric | ALDX | CCLD |
|---|---|---|
| Price | $0.92 | $2.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.60 | ★ $7.33 |
| AVG Volume (30 Days) | ★ 950.4K | 217.8K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.43 | ★ 135.71 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $120,499,000.00 |
| Revenue This Year | N/A | $8.14 |
| Revenue Next Year | N/A | $9.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.72 |
| 52 Week Low | $1.07 | $1.99 |
| 52 Week High | $5.93 | $3.85 |
| Indicator | ALDX | CCLD |
|---|---|---|
| Relative Strength Index (RSI) | 31.33 | 40.23 |
| Support Level | N/A | $2.04 |
| Resistance Level | $1.58 | $2.42 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.00 | 27.08 |
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.